7 completed, 1 terminated. 8 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 8 | Completed 7, Terminated 1 |
| Phase 3 | 1 | Completed 1 |
Follow Flortaucipir F18: new trials by email Literature Review of Flortaucipir F18 trials Research Report on Flortaucipir F18
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Cognitive Decline and Alzheimer's Disease in the Dallas Lifespan Brain Study [18F]AV-1451, Positron Emission Tomography - Alzheimer Disease, Cognitive Decline | Phase 2 | Completed | Neil M Rofsky, MD, MHA | 125 | 2019-01-15 | 2023-09-28 |
| Tau Screening Study in Subjects With Early Symptomatic AD Flortaucipir F18, Brain PET Scan - Alzheimer Disease | Phase 2 | Completed | Avid Radiopharmaceuticals | 161 | 2018-03-08 | 2020-08-24 |
| Tau Screening Study in Patients With Early Symptomatic AD Flortaucipir F18, Brain PET Scan - Alzheimer Disease | Phase 2 | Completed | Avid Radiopharmaceuticals | 155 | 2017-11-21 | 2020-08-24 |
| Follow up 18F-AV-1451 Scan in Confirmatory Cohort Subjects From Study 18F-AV-1451-A05 Flortaucipir F18, PET Scan - Alzheimer's Disease | Phase 2 | Completed | Avid Radiopharmaceuticals | 79 | 2016-08-01 | 2020-08-24 |
| Clinical Evaluation of Flortaucipir F 18 Flortaucipir F18, Brain PET scan - Alzheimer's Disease, Traumatic Brain Injury | Phase 2 | Completed | Avid Radiopharmaceuticals | 179 | 2014-12-01 | 2020-09-10 |
| 18F-AV-1451 and Florbetapir F 18 PET (Positron Emission Tomography) Imaging in Subjects at Risk for Chronic Traumatic Encephalopathy florbetapir F 18, Flortaucipir F18 - Chronic Traumatic Encephalopathy | Phase 2 | Completed | Avid Radiopharmaceuticals | 41 | 2014-06-01 | 2020-09-07 |
| Imaging Characteristics of a Follow-up 18F-AV-1451 Scan Flortaucipir F18, Florbetapir F 18, Brain PET Scan - Alzheimer's Disease | Phase 2 | Terminated | Avid Radiopharmaceuticals | 44 | 2014-05-01 | 2020-09-07 |
| Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI, and AD Subjects florbetapir F 18, Flortaucipir F18, Brain PET Scan - Alzheimer's Disease | Phase 2 / Phase 3 | Completed | Avid Radiopharmaceuticals | 383 | 2013-12-01 | 2020-09-22 |
Alzheimer Disease (7) · Brain Injuries, Traumatic (1) · Chronic Traumatic Encephalopathy (1) · Cognitive Dysfunction (1) · Depression (1)
Avid Radiopharmaceuticals (7) · Neil M Rofsky, MD, MHA (1)
United States (8) · Canada (1)
Denise Park, PhD (1)